NASDAQ:CMPX

Compass Therapeutics Stock Predictions

etoro logo Buy CMPX
*Your capital is at risk
$2.10
+0.0200 (+0.96%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

CMPX Prediction Chart

CMPX Predictions History

Latest community submissions for CMPX.
Predictor Target Session Target Price Result Direction Accuracy Score
Mar 3, 2025 $2.98 +2.60% $2.73 X 91.01% 0
Mar 3, 2025 $3.90 +34.48% $2.73 X 57.14% 0
Feb 28, 2025 $3.04 +4.27% $2.90 X 95.01% 0
Feb 28, 2025 $3.00 +2.67% $2.90 X 96.62% 0
Feb 28, 2025 Bullish $2.90 X 0
Feb 28, 2025 $4.35 +46.46% $2.90 X 50.00% 0
Feb 21, 2025 $3.21 +4.38% $2.92 X 89.90% 0
Feb 21, 2025 $3.16 +2.74% $2.92 X 91.63% 0
Feb 21, 2025 Bullish $2.92 X 0
Feb 19, 2025 $3.31 +4.31% $3.38 V 97.83% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CMPX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT COMPASS THERAPEUTICS, INC.
Compass Therapeutics
Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, develops proprietary antibody-based therapeutics to treat multiple human diseases. The company's product candidates include CTX-009, an investigational bispecific antibody, which is in Phase II clinical trial for biliary tract cancers, as well as Phase Ib clinical trial for colorectal and ovarian cancer; CTX-471, a monoclonal antibody product candidate that i...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE